CRISPR Therapeutics · 8 hours ago
Director, Clinical Development AID
CRISPR Therapeutics is a leader in gene editing with a diverse portfolio of product candidates across various disease areas. The Director of Clinical Development AID will provide clinical and scientific input for early-stage clinical development programs in autoimmune diseases, overseeing clinical study deliverables and collaborating with various stakeholders to ensure successful execution of clinical trials.
BiopharmaBiotechnologyGeneticsMedical
Responsibilities
Lead the scientific development of individual clinical studies in alignment with the clinical development plan, including authoring and reviewing clinical documents (e.g., protocols, investigators brochure, eCRFs, ICFs, CSRs)
Perform review of clinical trial data (safety and efficacy), including medical monitoring and assessing for consistency and completeness and providing assessments and recommendations
Serve as the clinical development lead during the conduct of the study
Communicate a clear overview of trial results
Collaborate with internal stakeholders (clinical operations, data management, statistics, safety, commercial, and regulatory affairs) to ensure translation of the clinical protocol into operational deliverables
Review and synthesize scientific literature and competitive intelligence to support study and program strategy
Develop scientific and protocol training presentations to support internal and external meetings; e.g., site qualification and initiation, investigator meetings, and training materials
Drive and support preparation of scientific material for conference presentations or publications
Contribute to the authoring and revision of regulatory submissions
Perform analyses and generate scientific slide decks based on clinical, translational and other datasets
Qualification
Required
Medical Doctorate (MD, DO, MBBS)
Advanced clinical training or a scientific degree in immunology (eg PhD, PharmD, MPH, etc) a plus
8+ years of previous experience in clinical or related research preferred
Excellent oral and written communication skills and analytical skills
Ability to work collaboratively in a fast-paced, team-based matrix environment; ability to assume multiple roles and responsibilities and meet stretch goals
Familiarity with ICH, GCP, and relevant regulatory requirements, and strong analytical and strategic thinking skills, experience with interacting with medical monitors, development operations (preclinical, clinical operations, regulatory affairs, Quality Assurance) and clinical investigators
Preferred
MD with a strong clinical or biopharmaceutical background in caring for patients with autoimmune diseases
Clinical or research experience in immunology or neurology
Benefits
Bonus
Equity
Benefits
Company
CRISPR Therapeutics
CRISPR Therapeutics is focused on the development of transformative medicines using its proprietary CRISPR/Cas9 gene-editing platform.
Funding
Current Stage
Public CompanyTotal Funding
$407MKey Investors
EcoR1 CapitalBill & Melinda Gates FoundationVersant Ventures
2024-02-13Post Ipo Equity· $280M
2020-12-14Grant
2016-10-19IPO
Recent News
2026-01-13
The Motley Fool
2026-01-13
2026-01-13
Company data provided by crunchbase